A rapid method for measuring nicotine concentration in serum and urine is described. Deuterated nicotine is used as an internal standard. Nicotine and de ute rated nicotine are extracted using a copolymeric-bonded phase silica column. The extract is analysed by gas chromatography coupled with mass spectrometry (GCjMS) operating in selected ion monitoring mode. The method has a lower limit of detection of approximately 2 flg(L and is linear to at least 2000 flg/L. Within-run percentage coefficients of variation (% CY) are < 4 in both assays over a nicotine concentration range of I G-2000 flg/L. Between-run %CY in the serum assay are 5-4, 5'2, 4·8 and 5·9, respectively, at nicotine concentrations of 10, 15, 25, and 50 flg/L. Between-run %CY in the urine assay are 5·9, 4'5, 2·7 and 5·2, respectively, at nicotine concentrations of 100, 250, 500, and 2000 flg/L. The absolute recovery of nicotine is 61 ±6% (mean ±SD) over the range of 10-250 flg/L. The assay has been used to measure serum nicotine concentrations and 24-h urinary excretion of nicotine to monitor the extent of replacement in subjects receiving transdermal nicotine therapy for smoking cessation.
INTRODUCTION
Nicotine is a ditertiary base with pyridine and Nmethyl pyrrolidine moieties. It is a highly potent and addictive neuropharmacological agent that is derived from several plants, most importantly the tobacco (Nicotiana) species. Today, over one-quarter of adult Americans inhale it as tobacco smoke despite common knowledge of the manifold hazards of smoking, including at least 43 carcinogens and several toxins as well as carbon monoxide.':" Although many individuals have been able to stop smoking, it has been assumed that the highly addictive nature of nicotine is a primary factor in the more intransigent cases." Nicotine replacement has been introduced as a therapeutic adjunct to education and behaviour modification in order to aid smoking cessation.
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Nicotine chewing gum has been the most common mode of administration, although other modalities, such as aerosol and nasal spray, have been used.I.2·K 10 Skin patches providing transdermal administration have also been developed. I I 14 The introduction of nicotine replacement therapy has led to the need to determine the optimal therapeutic dose and to monitor its use. This necessitates the ability to quantitate serum nicotine concentrations. Several chromatographic methods for nicotine analysis have been described. These techniques generally require liquid-liquid extraction for specimen cleanup prior to chromatography since nicotine is a weak base (pK a l = 6· I 6 and pK a2 = 10,96) that partitions into organic solvents under alkaline conditions. Separation methods include high performance liquid chromatography (HPLC),15.16 and gas chromatography using a nitrogen-phosphorus detector 17 21 or gas chromatography/mass spectrometry (GC/MS). [22] [23] [24] [25] [26] In attempting to implement a nicotine assay based upon existing liquid chromatographic methods, we experienced difficulties in attaining consistent quantitative results, which appeared to be related to the differential behaviour of nicotine and some commonly used internal standards. This problem was most easily solved by incorporating deuterated nicotine (0 3nicotine) as an internal standard and using GC/ MS in selected ion monitoring mode as the basis for detection and quantitation.Pr'" We report the development ofa rapid nicotine detection method requiring a single solid-phase extraction of nicotine and Dj-nicotine from serum or urine which facilitates high sample throughput.
MATERIALS AND METHODS
Nicotine (-) hydrogen tartrate salt was purchased from Sigma Chemical Co., St. Louis, MO, USA. Dj-nicotine [nicotine containing three deuterium (H 2) atoms in the methyl group bound to the pyrrolidine ring] was purchased from MSO Isotopes (Montreal, PQ, Canada). Methanol, isopropanol, ethyl acetate, hexane, and methylene chloride were HPLC grade. Ammonium hydroxide (30%) and glacial acetic acid were reagent grade. Bovine calf serum was purchased from Pel-Freez Biologicals (Rogers, AR, USA). Dry grade nitrogen was used for drying the eluate. Chromatographic grade helium was used as the carrier gas for chromatography. Clean Screen Worldwide Monitoring DAU (extraction columns; catalog no. ZSOAU020)] were purchased from United Chemical Technologies, Inc. (Horsham, PA, USA). The 12-place vacuum manifold used in the extraction was purchased from SupeIco, Inc. (Bellefonte, PA, USA). All glass tubes used in the assay were disposable.
Calibrators and internal standard Serum-based calibrators are prepared by adding a methanolic stock solution (100 mg/L of nicotine base) to bovine calf serum to produce solutions containing nicotine at final concentrations of 10, 15, 25, and 50/-lg/L. Urine-based calibrators are prepared by adding methanolic stock nicotine to human urine, obtained from a nonsmoker residing in a smoke-free household, to produce solutions having nicotine concentrations of 100, 250, 500 and 2000/-lg/L. Serum or urine blanks not spiked with nicotine were also included in each assay. The working internal standard is prepared by dissolving Dj-nicotine in methanol to a final concentration of 1·0 mg/L, Methanolic stock solutions of nicotine and Dr nicotine are stable for at least one year when stored in tightly capped containers at -20°C.
Extraction procedure Samples and calibrators (I mL) are pipetted into 3 mL disposable glass tubes. Working internal standard is added to each sample and calibrator: 0·05 mL for serum samples and 0·1 mL for urine samples. The samples are acidified with 1mL of 1·0 N acetic acid. After attaching the extraction columns to the vacuum manifold, each column is washed with 2 mL of methanol followed by 2 mL of water, taking care not to allow the column to dry. The acidified samples are then applied to the columns under low vacuum. The columns are further washed with 1 mL of 1·0 N acetic acid and allowed to dry in air for 2-5 min. They are then washed sequentially with 1mL of hexane, followed by 4 mL of hexane: ethyl acetate (50:50) to remove acidic components, and, finally, by 1mL of methanol and 1mL of methylene chloride. Nicotine and Dj-nicotine are eluted with 2 mL of isopropanol: ammonium hydroxide: methylene chloride (20:2:78). This solution must be prepared fresh daily. The eluates are collected in 5 mL glass tubes, evaporated under nitrogen at 22°C and reconstituted with 0·1 mL of methanol. The reconstituted eluates are transferred to glass injection vials, capped, and injected into the GC/MS.
Chromatographic procedure
Analysis was performed on a Hewlett Packard (Palo Alto, CA, USA) 5890 gas chromatograph interfaced to a Hewlett Packard 5988 electron impact quadrupole mass spectrometer operated in selected ion monitoring mode. The GC was equipped with a fused silica capillary column (15mxO·32mm 1.0.) containing OB-5M5 as stationary phase (1.0/-lm film thickness) obtained from J and W Scientific (Folsum, CA, USA). One /-IL of extract was injected in splitless mode. The temperatures of the injection port, interface, and source were 250, 275, and 250°C, respectively. The initial oven temperature was 85°C and was increased at a rate of 30°C/min to a final temperature of 300°C. Helium was used as the carrier gas at an appropriate flow rate of I ml.jrnin. Under these conditions, nicotine eluted with a retention time of approximately 3·5min. Electron multiplier voltage was set to approximately 2600 mV. The voltage was varied to optimize the assay, and was set higher for serum than urine because of the lower nicotine concentration in serum. Ion currents at the following mass-to-charge ratios (m/z) were monitored: 84, 133, and 162 nicotine and 87, 136, and 165 for Dj-nicotine. The dwell time for each ion was 25 ms.
Calculations
The m/z of the 84 and 87 peaks from the single ion chromatograms are integrated and used to calculate the m/z 84/87 peak area ratio. A least squares calibration curve is generated by plotting this ratio against the assigned nicotine concentration. The m/z 84/87 peak area ratio in the samples are compared against this curve to calculate the nicotine concentration in !J.g/L. Fig. 1 shows the electron impact mass spectra for nicotine and Dj-nicotine. The three major ions characteristic of the mass spectrum of nicotine have m/z values of 84, 133, and 162, while Dj-nicotine generates analogous ions of m/z 87, 136, and 165. The structures of the molecular ions along with presumptive structures of the more prominent fragments are also shown. In selected ion monitoring mode, nicotine in a sample was quantitated by determining the m/z 84/87 peak area ratio and comparing this against a calibration curve generated from m/z 84/87 ratios derived from standards of known nicotine concentrations included in the same run. The other ions were monitored to detect possible interfering substances, since all monitored ions will have identical retention times and exhibit ratios that are specific for nicotine or Dj-nicotine. An example of the single ion chromatograms for a serum sample with an assayed nicotine concentration of 6 !J.g/L and Dj-nicotine of 50 !J.g/L is shown in Fig. 2 . Examples of typical calibration curves for the serum and urine assays are shown in Fig. 3 curves, respectively. The y-intercept of the serum calibration is not exactly zero because a small amount of nicotine is recovered in unspiked bovine serum. The assayed concentration is generally < I· 5 J.lgjL and appears to be a contaminant present in the Dj-nicotine internal standard used in these studies. For this reason, the blank is included as one of the calibrators. The assay limit of detection was determined by assaying the blank on a sample in 20 separate assays. The mean + 3 SD = 1.5 J.lgjL, so that the limit of detection was set at 2 J.lgjL. Within-run percentage coefficients of variation (%CV), determined from 10 replicate determinations of spiked serum or urine-based samples extracted in the same batch, were < 4 over the nicotine concentration range of 10-2000 gjL. Between-run %CV calculated from controls (bovine serum or blank urine spiked with nicotine to known concentration) included with each batch of samples assayed over a 9month period are < 6 ( Table I) . Absolute recoveries were calculated by measuring peak areas of the mjz 84 single ion chromatograms obtained on serum-based standards taken through the extraction process and comparing with methanol-based standards analysed directly N = Number of determinations; * = nicotine added to bovine serum to the indicated concentrations; **= nicotine added to blank human urine to the indicated concentration.
RESULTS
by GCfMS. An overall absolute recovery of 61 ±6% (mean j Sfr) was obtained over the range of 10 to 250/lg/mL and was consistent over the entire range. Although absolute recoveries were determined using a single lot number of extraction columns, this may be expected to vary due to lot-to-Iot variability. However, this assay has been utilized for several years using numerous lots without significant effects on the assay.
DISCUSSION
During initial attempts to apply HPLC using various nicotine analogues as internal standards (nicotine, anabasine, 2-phenyl imidazole) we were unable to achieve the desired precision at nicotine concentrations below 10 /lg/L. The concern of identifying an optimal internal standard has been expressed by other investiga-torS. 17 . 19 ,25 Moreover, the signal-to-noise ratio in our system was low and we were concerned about possible interferences which might be difficult to recognize with a one-dimensional detection system. Several methods have been reported using GC/MS and deuterated nicotine as internal standard. 23 • 25 ,26 Our method uses this technology and incorporates a simple extraction step to minimize pre-analytical sample preparation, an important consideration if a large number of samples will be assayed. A laboratory technologist can easily prepare extracts from 24
Ann Clin Biochem 1998: 35 samples in less than an hour including downtime.
The m/z 84 base ion is used for quantification because of its much greater abundance compared to the m/z 133 and 162 ions, thereby giving greater precision in the low concentration range. We were initially concerned that use of such a low mass ion would render the assay susceptible to interference from endogenous compounds in the serum and urine matrices. To detect possible interference, the m/z 133/84 and 162/84 ion ratios are monitored routinely for nicotine as are the m/z 136/87 and 165/87 ratios for Dj-nicotine. To date, the assay has been applied to approximately 3000 serum and 500 urine samples, and no interferences have been observed. Thus, the routine monitoring of ion ratios seems more a formality than a necessity.
The laboratory in which the nicotine assay is performed is in a smoke-free building with good ventilation and restricted access. Although none of the individuals who work in that laboratory use tobacco, no other special precautions were deemed necessary to prevent contamination of the samples, as described by others. If> 20.22 As stated above, the small nicotine background in the bovine serum matrix appears to be a contaminant of the deuterated internal standard.
In summary, we describe an assay for quantifying nicotine in serum and urine that uses solid-phase extraction, GCfMS analysis with selected ion monitoring, and Dj-nicotine as an internal standard. The assay is precise, specific, has a limit of detection of 2/lg/L, and is linear well beyond the range of nicotine normally observed in serum and urine. It is easy to perform and relatively inexpensive for laboratories already equipped to perform GC( MS analysis.
